| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.045 | 0.4 |